Improving Access and Quality of Care for Kidney Stone Patients in an Underserved Community.


Journal

Journal of endourology
ISSN: 1557-900X
Titre abrégé: J Endourol
Pays: United States
ID NLM: 8807503

Informations de publication

Date de publication:
04 2023
Historique:
medline: 6 4 2023
pubmed: 3 12 2022
entrez: 2 12 2022
Statut: ppublish

Résumé

There is a call to improve Medicaid patient access to health care, enhance quality and outcomes of care, and reduce overall financial burden. We sought to build a comprehensive kidney stone program to help patients navigate through the acute and preventive aspects of stone disease by increasing multidisciplinary referrals and compliance with recommendations and decreasing no-show rates at first follow-up and repeat stone encounters after initial evaluation. A collaborative multidisciplinary program was established at our single institution consisting of urology, nephrology, and dietary specialists to be piloted over a 3-year period. Medicaid-designated patients were evaluated during new patient encounters by urology specialists and then followed for outpatient follow-up, including specialty referrals to nephrology specialists and dietitians, for targeted preventive measures. Subjective compliance reports by patients following interventions and no-show rates at subsequent follow-ups were documented. We also followed patients 6 months beyond the initial encounter to assess repeat Emergency Department (ED) visits for acute stone episodes. One hundred eighty-three Medicaid-designated stone patients were evaluated from 2018 to 2021. Sixty-eight percent of patients identified as White, 18% identified as Black/African American, and 14% identified as "Other." Patients underwent specialty referrals to nephrology or a dietician in 47% and 42% of cases, respectively. Since the program's implementation, reported patient compliance and referrals to multidisciplinary specialists increased from 72.9% to 81.30% and 21.2% to 56.20%, respectively. Repeat ED visits for stone-related encounters within 6 months of initial presentation remained relatively stable (from 17.60% to 18.9%), while no-show rates at first follow-up decreased from 20.0% to 6.30% by study conclusion. There is continued supporting evidence for the importance of a comprehensive kidney stone program specifically for patients of lower socioeconomic status following a 3-year implementation at our institution. Encouraging results indicate increased access to multidisciplinary specialty referrals, with improvement in follow-up and reported compliance related to stone prevention strategies.

Identifiants

pubmed: 36458470
doi: 10.1089/end.2022.0564
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

467-473

Auteurs

Megan Stout (M)

Department of Urology and The Ohio State Wexner Medical Center, Columbus, Ohio, USA.

Molly Mcnamara (M)

The Ohio State University College of Medicine, Columbus, Ohio, USA.

Tasha Posid (T)

Department of Urology and The Ohio State Wexner Medical Center, Columbus, Ohio, USA.

Alicia Scimeca (A)

Department of Urology and The Ohio State Wexner Medical Center, Columbus, Ohio, USA.

Aliza Khuhro (A)

The Ohio State University College of Medicine, Columbus, Ohio, USA.

Matthew Murtha (M)

Department of Urology and The Ohio State Wexner Medical Center, Columbus, Ohio, USA.

Max Yudovich (M)

Department of Urology and The Ohio State Wexner Medical Center, Columbus, Ohio, USA.

Dinah Diab (D)

Department of Urology and The Ohio State Wexner Medical Center, Columbus, Ohio, USA.

Ganesh Shidham (G)

Department of Nephrology, The Ohio State Wexner Medical Center, Columbus, Ohio, USA.

Elizabeth Weinandy (E)

Department of Nutrition and Dietetics, The Ohio State University, Columbus, Ohio, USA.

Bodo E Knudsen (BE)

Department of Urology and The Ohio State Wexner Medical Center, Columbus, Ohio, USA.

Michael W Sourial (MW)

Department of Urology and The Ohio State Wexner Medical Center, Columbus, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH